Arterial intervention and percutaneous puncture ablation for comprehensive treatment of liver cancer

Abstract

Objective To investigate the efficacy of arterial intervention and percutaneous puncture ablation on patients with liver cancer. Methods Seventy-eight patients with hepatocellular carcinoma who were scheduled to survive for more than 6 months from August 2015 to March 2017 in the Fifth People’s Hospital of Datong were randomly divided into two groups using random number expression, with 39 cases in each group. Thirty-nine patients in the observation group were treated with femoral artery puncture to treat liver tumors and combined with percutaneous puncture ablation. In the control group, 39 patients were treated with femoral artery puncture to treat liver tumors. The therapeutic effects in the two groups were statistically analyzed. The expression level of alpha-fetal protein was measured. The quality of life and bone marrow suppression rate were investigated in 78 patients. Results The quality of life and total effective rate of treatment in the observation group were significantly better than those in the control group(P<0.05). The bone marrow suppression rate in the observation group was significantly lower than that in the control group(P<0.05). The level of alpha-fetoprotein in the observation group were lower than that in the control group(P<0.05). Conclusions Arterial intervention and percutaneous puncture ablation combined treatment of patients with liver cancer is beneficial to reduce the incidence of adverse reactions, improve the prognosis and the quality of life. And its clinical efficacy is significantly better than single treatment, which can significantly reduce the level of alpha-fetal protein. It is worthy of clinical application and promotion. Key words: Artery interventional therapy; Percutaneous puncture ablation; Liver cancer